scholarly journals Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

2017 ◽  
Vol 38 (5) ◽  
pp. 821-833 ◽  
Author(s):  
K. Rajender Reddy ◽  
Stanislas Pol ◽  
Paul J. Thuluvath ◽  
Hiromitsu Kumada ◽  
Joji Toyota ◽  
...  
2018 ◽  
Vol 154 (6) ◽  
pp. S-1081
Author(s):  
Andrew J. Muir ◽  
Alessandra Mangia ◽  
Eric Lawitz ◽  
Edward Gane ◽  
Brian Conway ◽  
...  

2001 ◽  
Vol 127 (3) ◽  
pp. 485-492 ◽  
Author(s):  
J. F. HUANG ◽  
S. N. LU ◽  
P. Y. CHUE ◽  
C. M. LEE ◽  
M. L. YU ◽  
...  

The aim of the study was to elucidate the epidemiological features of Hepatitis C virus (HCV) infection among teenagers in an endemic area by conducting a mass screening study. We also investigated the clinical outcome of the anti-HCV-positive subjects by conducting subsequent short-term and long-term follow-up studies. All 2837 students of two junior middle schools in Tzukuan, aged 13–16 years, were invited to be screened for anti-HCV, HBsAg, AST and ALT in October 1995. A total of 2726 (96%) students responded. Anti-HCV, HCV RNA and aminotransferase levels were evaluated among anti-HCV-positive students 1 month and 30 months later, respectively. A total of 38 (1·4%; M/F = 22/16) participants were anti-HCV-positive. The anti-HCV-positive students had higher rates of exposures to transfusion, anti-HCV-positive families and surgery. The prevalence (2·8%) of the 7 maritime villages was markedly higher than that (0·7%) of the other 8 villages (P < 0·001). Subsequent follow-up studies demonstrated that there might be 5 cases of acute or recent HCV infection, and 6 cases who had recovered from chronic HCV infection.


Sign in / Sign up

Export Citation Format

Share Document